Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
MD, specialised in Industrial Medicine and in Hygiene, at the University of Turin (Italy).
Master degree in Public Health and Epidemiology at the University of Washington, Seattle (USA).
I am currently employed at the Centre of Oncology Prevention (CPO-Piemonte) in Turin.
Since the early nineties I am responsible for the organisation and evaluation of breast cancer screening programmes. I found screening of outstanding interest for its multidisciplinary nature and I soon got involved in the Quality Assurance (QA) of breast cancer screening, diagnosis and treatment.
I have served for two terms in the European Society of Breast Cancer Specialists (EUSOMA) executive board and I am currently Director of the EUSOMA Data Centre, including a large database of certified Breast Units.
I have been project leader in European collaborative projects on QA and on breast cancer screening within the European Cancer Screening Network.
I have been PI of a large survey on Ductal carcinoma in situ within the International Cancer Screening Network, a project sponsored by the National Cancer Institute, USA.
At present I am PI of the second implementation report on cancer screening in the European Union.